Versatile

Educational and Networking Events for the Life Sciences Industry

PTS2012banneri

Information

Join Our Mailing List

Please enter your contact details below in order to receive regular updates and discount offers for this conference.

First Name           
Last Name           
Job Title                
Company             
Email Address    

Join our Pain Drug Development Group

linkedin.1.u

Gold Sponsor

 

Lifetree Clinical Research® is in the forefront of experimental pain models (UVB, Capsaicin, Micro-Incision and Cold Pressor) in healthy volunteers to demonstrate efficacy early in drug development. CNS, Analgesia, Human Abuse Liability, and CSF are Lifetree’s sought after niche services. Clients look to Lifetree for quality Site and CTM Services.

Silver Sponsor

algos_logo

Algos is a premier contract research organization specializing in preclinical pain in rodent models. They perform Proof-of concept, Screening and Efficacy studies in a wide range of in vivo models including neuropathic, post-surgical, visceral and inflammatory pain. Their expertise, quality and customer service enable clients to augment their drug discovery efforts.

Last Year's Conference

Please CLICK HERE to view last year's conference agenda

lastyearsconference

Networking Opportunities

Attendees will have the opportunity to network before during and after the event through the following services:

  • ONLINE NETWORKING software available prior to and after the event
  • ONE-to-ONE meeting space
  • NETWORKING breaks
  • End of day RECEPTION
 

 

About this Conference

ARROWHEAD’S ANNUAL PAIN THERAPEUTICS SUMMIT is the US’s premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors.

This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.

 

Key Themes at this Year's Summit

  • Clinical trial endpoints in pain - is it time to move beyond pain intensity?
  • Real-time fMRI (functional magnetic resonance imaging) for pain
  • Analysis of CGRP antagonist, NGF antagonist, TRPV1 antagonist, Nav 1.7 antagonist, and P2x receptor antagonist clinical development programs
  • Programmable devices and therapeutics for patient-controlled analgesia
  • Analysis of new drug discovery targets
  • Exploration and analysis of animal models for pain
  • Abuse-resistant opioid formulations in clinical development
  • Combination therapy approaches to pain management
  • Treatment strategies for opioid-induced constipation
  • Clinical development status of longer-acting analgesics for post-operative pain
  • Review and analysis of key developmental stage therapies for nociceptive pain, neuropathic pain, migraine, back pain, fibromyalgia, cancer pain, arthritic pain, acute pain and chronic pain
  • The future role of pharmacogenomics, biomarkers and translational research in the development of therapeutics for pain
  • An examination of regulatory hurdles facing developers of new pain therapies
  • Abuse liability and safety issues affecting the developers of opioids
  • Analysis and case studies of successful commercialization strategies for pain therapies
 

Who Should Attend

VPs, Managers, Heads, Directors and Associates from the areas of:

  • Pain research
  • Neuroscience drug discovery
  • Pain management
  • Clinical development/research
  • Business development/licensing
  • Alliance management
  • Drug delivery
  • Pain management devices

as well as individuals from

  • Investment banks and venture capitalist firms
  • Academic institutions
  • Consultancies

Reasons to Attend

LEARN about the latest developments and the most recent commercial breakthroughs in the area of pain therapeutics

GAIN a better sense of the impact the biotech industry is having on the development of pain therapeutics

DISCOVER what innovative new therapies are driving investment and clinical development in the area of pain therapeutics

NETWORK with leaders from the pharma, biotech, specialty pharma and drug delivery industries as well as the academic community and government

BETTER UNDERSTAND the specific and implications of groundbreaking new research in the field of pain therapeutics

ACQUIRE a holistic view of the field of pain therapeutics from the perspective of scientists, clinicians and commercial executives